業績

2015年度 :: 著書・雑誌 :: 英文 :: 原著 :: 業績

Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β-induction by efficient MAVS cleav- age.

Welsch C, Haselow K, Gouttenoire J, Schneider M, Morikawa K, Martinez Y, Susser S, Sarrazin C, Zeuzem S, Antes I, Moradpour D, Lange CM.

J Hepatol. 2015; 62(4): 779-784

Intratumoral artery on contrast-enhanced computed tomog- raphy imaging: differentiating intrahepatic cholangiocarcino- ma from poorly differentiated hepatocellular carcinoma.

Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N.

Abdom Imaging. 2015; 40(6): 1492-1499

Occurrence of adverse events caused by valganciclovir as preemptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.

Takahata M, Hashino S, Nishio M, Sugita J, Shigematsu A, Onozawa M, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T.

Transpl Infect Dis. 2015; 17(6): 810-815

Serum granulysin levels as a predictor of serious telapre- vir-induced dermatological reactions.

Suda G, Yamamoto Y, Nagasaka A, Furuya K, Kudo M, Chuganji Y, Tsukuda Y, Tsunematsu S, Sato F, Terasita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Fujita Y, Abe R, Taniguchi M, Nakagawa M, Asahina Y, Sakamoto N.

Hepatol Res. 2015; 45(8): 837-845

Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.

Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J, Shigematsu A, Hashimoto D, Ebdo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T.

Hematol Oncol. 2016; 34(1): 9-16

Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.

Shiratori S, Kosugi-Kanaya M, Shigematsu A, Konayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Tsutsumi Y, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T.

Leuk Lymphoma. 2015; 56(9): 2592-2597

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.

Sato F, Kubota Y, Natsuizaka M, Maehara O, Hatanaka Y, Marukawa K, Terashita K, Suda G, Ohnishi S, Shimizu Y, Komatsu Y, Ohashi S, Kagawa S, Kinugasa H, Whelan K, Rustgi A, Nakagawa H, Sakamoto Naoya.

Cancer Biol Ther. 2015; 16(6): 933-940

Early use of double-guidewire technique to facilitate selective bile duct cannulation: the multicenter randomized controlled EDUCATION trial.

Sasahira N, Kawakami H, Isayama H, Uchino R, Nakai Y, Ito Y, Matsubara S, Ishiwatari H, Uebayashi M, Yagioka H, Togawa O, Toda N, Sakamoto N, Kato J, Koike K.

Endoscopy. 2015; 47(5): 421-429

Effect of human amnion-derived mesenchymal stem cell transplantation in rats with radiation proctitis.

Ono M, Ohnishi S, Honda M, Ishikawa M, Hosono H, Onishi R, Nakagawa K, Takeda H, Sakamoto N.

Cytotherapy. 2015; 17(11): 1545-1559

Human amnion-derived mesenchymal stem cell transplan- tation ameliorates dextran sulfate sodium-induced severe colitis in rats.

Onishi R, Ohnishi S, Higashi R, Watari M, Yamahara K, Okubo N, Nakagawa K, Katsurada T, Suda G, Natsuizaka M, Takeda H, Sakamoto N.

Cell Transplant. 2015; 24(12): 2601-2614

Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis.

Matsumoto M, Mabe K, Tsuda M, Ono M, Omori S, Takahashi M, Yoshida T, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, Kudo T, Sakamoto N, Kato M.

BMC Gastroenterol. 2015; 15: 89

Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multi- center prospective observational study.

Matsuhashi N, Kudo M, Yoshida N, Murakami K, Kato M, Sanuki T, Oshio A, Joh T, Higuchi K, Haruma K, Nakada K.

J Gastroenterol. 2015; 50(12): 1173-1183

A pivotal role of Kr?ppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma.

Maehara O, Sato F, Natsuizaka M, Asano A, Kubota Y, Itoh J, Tsunematsu S, Terashita K, Tsukuda Y, Nakai M, Sho T, Suda G, Morikawa K, Ogawa K, Chuma M, Nakagawa K, Ohnishi S, Komatsu Y, Whelan KA, Nakagawa H, Takeda H, Sakamoto N.

Cancer Biol Ther. 2015; 16(10): 1453-1461

Human amnion-derived mesenchymal stem cell transplantation ameliorates liver fibrosis in rats.

Kubo K, Ohnishi S, Hosono H, Fukai M, Kameya A, Higashi R, Yamada T, Onishi R, Yamahara K, Takeda H, Sakamoto N.

Transplant Direct. 2015; 1: e16

Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combina- tion chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.

Komatsu Y, Ishioka C, Shimada K, Yamada Y, Gamoh M, Sato A, Yamaguchi T, Yuki S, Morita S, Takahashi S, Goto R, Kurihara M.

BMC Cancer. 2015; 15: 626

Oopen-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palono- setron.

Komatsu Y, Okita K, Yuki S, Furuhata T, Fukushima H, Masuko H, Kawamoto Y, Isobe H, Miyagishima T, Sasaki K, Nakamura M, Ohsaki Y, Nakajima J, Tateyama M, Eto K, Minami S, Yokoyama R, Iwanaga I, Shibuya H, Kudo M, Oba K, Takahashi Y.

Cancer Sci. 2015; 106(7): 891-895

Randomized controlled trial on the skin toxicity of panitu- mumab in Japanese patients with metastatic colorectal cancer:HGCSG1001. Study: J-STEPP.

Kobayashi Y, Komatsu Y, Yuki S, Fukushima H, Sasaki T, Iwanaga I, Uebayashi M, Okuda H, Kusumi T, Miyagishima T, Sogabe S, Tateyama M, Hatanaka K, Tsuji Y, Nakamura M, Konno J, Yamamoto F, Onodera M, Iwai K, Sakata Y, Abe R, Oda K, Sakamoto N.

Future Oncol. 2015; 11(4): 617-627

Endoscopic ultrasound-guided choledochoduodenostomy vs. transpapillary stenting for distal biliary obstruction. -PubMed-NCBI

Kawakubo K, Kawakami H, Kuwatani M, Kubota Y, Kawahata S, Kubo K, Sakamoto N.

Endoscopy. 2016; 48(2): 164-169

Feasibility of using an enzymatically activatable fluorescence probe for the rapid evaluation of pancreatic tissue obtained using endoscopic ultrasound-guided fine needle aspiration: A pilot study.

Kawakubo K, Ohnishi S, Hatanaka Y, Hatanaka KC, Hosono H, Kubota Y, Kamiya M, Kuwatani M, Kawakami H, Urano Y, Sakamoto N.

Mol Imaging Biol. 2016; 18(3): 463-471

Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease pro- gression in autoimmune hepatitis.

Hiraide A, Hiroishi K, Shimazaki T, Eguchi J, Ishii S, Morikawa K, Sakaki M, Doi H, Omori R, Kajiwara A, Hayashi E, Shiina M, Hirayama Y, Imawari M.

Hepatol Res. 2015; 45(11): 1152-1154

Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis.:a mul- ticenter, non-randomized, open-label and exploratory clinical trial.

Eto K, Kawakami H, Haba S, Yamato H, Okuda T,Yane K, Hayashi T, Ehira N, Onodera M, Matsumoto R, Matsubara Y, Takagi T, Sakamoto N.

J Hepatobiliary Pancreat Sci. 2015; 22(12): 825-830

Effect of a stylet on a histological specimen in EUS-guided fine-needle tissue acquisition by using 22-gauge needles: a multicenter, prospective, randomized, controlled trial.

Abe Y, Kawakami H, Oba K, Hayashi T, Yasuda I, Mukai T, Isayama H, Ishiwatari H, Doi S, Nakashima M, Yamamoto N, Kuwatani M, Mitsuhashi T, Hasegawa T, Hirose Y, Yamada T, Tanaka M, Sakamoto N; Japan EUS-FNA Stylet Study Group.

Gastrointest Endosc. 2015; 82(5): 837-844

>